Exploring the mechanism of YangXue QingNao Wan based on network pharmacology in the treatment of Alzheimer’s disease

It is clinical reported that YangXue QingNao Wan (YXQNW) combined with donepezil can significantly improve the cognitive function of AD patients. However, the mechanism is not clear. A network pharmacology approach was employed to predict the protein targets and affected pathways of YXQNW in the tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yuying, Guo, Kaimin, Zhang, Pengfei, Zhang, Mengying, Li, Xiaoqiang, Zhou, Shuiping, Sun, He, Wang, Wenjia, Wang, Hui, Hu, Yunhui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9465410/
https://www.ncbi.nlm.nih.gov/pubmed/36105078
http://dx.doi.org/10.3389/fgene.2022.942203

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9465410/
https://www.ncbi.nlm.nih.gov/pubmed/36105078
http://dx.doi.org/10.3389/fgene.2022.942203

Ejemplares similares